Munich Re's Capital Firepower Mounts as Reinsurance Pricing Squeeze Sends Shares Lower

Despite record Q1 profit, €2.25B buyback, and €3.6B Amprion sale, Munich Re shares fall 13% in 2026 amid reinsurance pricing cycle headwinds.

Munich Re is generating record profits, redeploying billions from a landmark infrastructure exit and aggressively buying back its own stock — yet the shares remain stuck in a downtrend that has erased 13% of their value since the start of 2026. The disconnect between the German reinsurer's operational strength and its market valuation is becoming harder to ignore.

The culprit is the reinsurance pricing cycle. At the critical June renewal round, property-catastrophe rates dropped by 15% to 20%, with loss-free programmes seeing declines of up to 25%. Munich Re has responded by shrinking its new business volume by 18.5% at the April renewal, accepting a 3.1% risk-adjusted price reduction in exchange for better portfolio quality. The discipline is clear, but the headwind is real.

None of this is visible in the first-quarter numbers. Net profit soared 57% year-on-year to €1.714 billion, the combined ratio in property-casualty reinsurance improved to 66.8%, and the solvency ratio landed at 292% — well above the 200% to 250% target range. Management has reaffirmed its full-year profit guidance of €6.3 billion.

To backstop the stock, Munich Re launched a €2.25 billion share buyback programme on 14 May, running until the annual general meeting on 29 April 2027. Between 10 and 18 June alone, the company repurchased 169,692 shares, bringing the total since inception to more than one million. All bought-back shares will be cancelled, providing a mechanical boost to earnings per share. So far, however, the effect on the share price has been modest. At Tuesday's close of €475.10 — down 0.4% on the day and roughly 21% below the 52-week high set in August 2025 — the stock is also trading about 10% below its 200-day moving average.

An even larger capital event is on the horizon. RWE is acquiring a controlling 55% stake in transmission grid operator Amprion from a consortium of financial investors that includes Talanx and Meag Munich Ergo, the asset manager jointly owned by Munich Re and Ergo. The total consideration for the stake is around €3.6 billion, and the transaction, which marks Munich Re's exit from a long-standing infrastructure holding, is expected to close by the end of September 2026, subject to regulatory approval. RWE has partly financed the purchase through a €4 billion rights issue.

Positive signals from the US property-casualty market are providing some offsetting tailwinds. American P&C insurers posted an underwriting profit of $15.8 billion in the first quarter, reversing a loss of $864 million a year earlier, while the industry-wide combined ratio improved to 92.4% from 99.2%. Lower catastrophe losses and better motor insurance results drove the improvement, lending support to global reinsurers such as Munich Re.

For investors, the next catalyst will be the completion of the Amprion sale, which will send fresh capital back into the group's balance sheet. But the bigger question is whether pricing in the reinsurance market will stabilise at the next renewal rounds. If it does, Munich Re's current valuation discount relative to peers such as Allianz and Hannover Re may look increasingly unjustified.